These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27538346)

  • 1. Phosphoneurofilament heavy chain and vascular endothelial growth factor as cerebrospinal fluid biomarkers for ALS.
    Gonçalves M; De Carvalho M; Peixoto C; Alves P; Barreto C; Oliva A; Pinto S; Laborinho-Pronto A; Gromicho M; Costa J
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):134-136. PubMed ID: 27538346
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.
    Oeckl P; Jardel C; Salachas F; Lamari F; Andersen PM; Bowser R; de Carvalho M; Costa J; van Damme P; Gray E; Grosskreutz J; Hernández-Barral M; Herukka SK; Huss A; Jeromin A; Kirby J; Kuzma-Kozakiewicz M; Amador Mdel M; Mora JS; Morelli C; Muckova P; Petri S; Poesen K; Rhode H; Rikardsson AK; Robberecht W; Rodríguez Mahillo AI; Shaw P; Silani V; Steinacker P; Turner MR; Tüzün E; Yetimler B; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):404-13. PubMed ID: 27415180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying putative cerebrospinal fluid biomarkers of amyotrophic lateral sclerosis in a north Indian population.
    Khosla R; Rain M; Chawathey S; Modgil S; Tyagi R; Thakur K; Pannu V; Sharma SK; Anand A
    Muscle Nerve; 2020 Oct; 62(4):528-533. PubMed ID: 32696574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature.
    Gagliardi D; Meneri M; Saccomanno D; Bresolin N; Comi GP; Corti S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis.
    Costa J; Streich L; Pinto S; Pronto-Laborinho A; Nimtz M; Conradt HS; de Carvalho M
    Mol Neurobiol; 2019 Aug; 56(8):5729-5739. PubMed ID: 30674035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.
    Gonçalves M; Tillack L; de Carvalho M; Pinto S; Conradt HS; Costa J
    Clin Chim Acta; 2015 Jan; 438():342-9. PubMed ID: 25261856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line.
    Vijayalakshmi K; Ostwal P; Sumitha R; Shruthi S; Varghese AM; Mishra P; Manohari SG; Sagar BC; Sathyaprabha TN; Nalini A; Raju TR; Alladi PA
    Mol Neurobiol; 2015; 51(3):995-1007. PubMed ID: 24880751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia.
    Just N; Moreau C; Lassalle P; Gosset P; Perez T; Brunaud-Danel V; Wallaert B; Destée A; Defebvre L; Tonnel AB; Devos D
    Neuromuscul Disord; 2007 Feb; 17(2):169-73. PubMed ID: 17142042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Nagata T; Nagano I; Shiote M; Narai H; Murakami T; Hayashi T; Shoji M; Abe K
    Neurol Res; 2007 Dec; 29(8):772-6. PubMed ID: 17672928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis.
    Heckler I; Venkataraman I
    J Neurophysiol; 2022 Mar; 127(3):737-745. PubMed ID: 35138963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF levels in CSF and serum in mild ALS patients.
    Gao L; Zhou S; Cai H; Gong Z; Zang D
    J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients.
    Gupta PK; Prabhakar S; Sharma S; Anand A
    J Neuroinflammation; 2011 May; 8():47. PubMed ID: 21569455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
    Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
    Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.
    Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M
    Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication.
    Matsuishi T; Nagamitsu S; Shoji H; Itoh M; Takashima S; Iwaki T; Shida N; Yamashita Y; Sakai T; Kato H
    J Neural Transm (Vienna); 1999; 106(9-10):943-8. PubMed ID: 10599876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of the vascular endothelial growth factor in CSF from early ALS patients.
    Devos D; Moreau C; Lassalle P; Perez T; De Seze J; Brunaud-Danel V; Destée A; Tonnel AB; Just N
    Neurology; 2004 Jun; 62(11):2127-9. PubMed ID: 15184633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases.
    Costa J; Pronto-Laborinho A; Pinto S; Gromicho M; Bonucci S; Tranfield E; Correia C; Alexandre BM; de Carvalho M
    Sci Rep; 2020 Mar; 10(1):5649. PubMed ID: 32221402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis.
    Ranganathan S; Williams E; Ganchev P; Gopalakrishnan V; Lacomis D; Urbinelli L; Newhall K; Cudkowicz ME; Brown RH; Bowser R
    J Neurochem; 2005 Dec; 95(5):1461-71. PubMed ID: 16313519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.